Regulatory Support CDMOs

Central Pharma Contract Packing Ltd

Ireland

Central Pharma Contract Packing Ltd is an Irish pharmaceutical contract packing company established in 2006, operating multiple sites across different countries. The company provides filling, packing, serialization, specialist storage and logistics, and regulatory support services for pharmaceutical, veterinary, medical device, cell and gene therapy, and healthcare products. Central Pharma has extensive FDA registration for labeling and packing operations across 9 FEI numbers.

China Resources Zizhu Pharmaceutical Co., Ltd. (CRZP), founded in 1969, is a high-tech pharmaceutical enterprise and subsidiary of China Resources Pharmaceutical. The company manufactures APIs and finished dosage forms including tablets, oral liquids, and topicals, with FDA registration and 5 FDA inspections on record, and 2 FDA-approved products.

Chiracon GmbH

Germany

Chiracon GmbH, founded in 1998, is a German API manufacturer and CDMO based in Brandenburg with over 25 years of experience. The company provides contract research, intermediates, scale-up, GMP-quality API manufacturing, stability studies, and clinical trial supplies for the pharmaceutical industry.

Clininvent Research Pvt Ltd

India

Clininvent Research Pvt Ltd (now TCG GreenChem Manufacturing Pvt Ltd) is a US FDA-inspected cGMP API manufacturing facility in Hyderabad, India, and a wholly-owned subsidiary of TCG Lifesciences. The company provides custom manufacturing services for active pharmaceutical ingredients including New Chemical Entities (NCEs), generic APIs, regulatory starting materials (RSMs), and intermediates, with all SOPs compliant with 21 CFR requirements.

Corealis Pharma Inc. is the same entity as Corealis Pharma, a privately held GMP-compliant CDMO based in Laval, Quebec, Canada. The company specializes in oral solid dosage forms, providing formulation development and cGMP clinical supply manufacturing for Phase I through early Phase III trials. Corealis has expanded its facilities in Laval's Biotech City with an investment of over $10 million and partners with Rottendorf Pharma and Bora Pharmaceuticals for integrated development-to-commercial services.

CYTOPHARMA (Cytopharma, Tunisia)

Tunisia

Cytopharma is a Tunisian pharmaceutical company specializing in oncology generic products. It has been described as a new entrant in Tunisian pharmaceutical manufacturing and the first company in Africa focused on generic oncology products. Very limited information is available as its website is under construction.

Dipharma Francis S.r.l.

Italy

Dipharma Francis S.r.l. is an Italian CDMO and manufacturer of Active Pharmaceutical Ingredients and advanced intermediates, offering exclusive synthesis services for custom API development and manufacturing alongside a catalogue of generic APIs. They have completed a second phase of cGMP expansion and operate multiple global locations supporting pharmaceutical customers from development through commercial supply.

Dishman Carbogen Amcis Ltd

China

Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.

Disphar International BV

Netherlands

Disphar International BV merged with QPharma in June 2021 to form Sever Pharma Solutions, part of the Sever Life Sciences group (a EUR 300M organization with 900 employees). The parent entity Esperante Development focuses on pharmaceutical product innovation and development. Search results confirm Disphar's CDMO heritage with personnel who went on to CDMO roles at Novartis and other companies.

Diverchim CDMO

France

Diverchim is a French boutique CDMO founded in 2000, specializing in developing and manufacturing small-quantity Active Pharmaceutical Ingredients including drug candidates, orphan drug APIs, and radiopharmaceutical precursors. They offer services from preclinical stage through commercial supply, with GMP certification since 2015, FDA site registration since 2021, and capabilities including lyophilization and solid aliquoting of radiopharmaceutical precursors.

Divis Laboratories Limited

India

Divis Laboratories is one of the world's top 3 API manufacturers and a trusted CDMO partner for over 25 years, serving 12 of the top 20 Big Pharma companies. Operating three world-class manufacturing facilities near Hyderabad, Visakhapatnam, and Kakinada in India with over 16,500 m3 combined reaction capacity, they manufacture generic APIs (30 commercial products), custom synthesis for Big Pharma (small molecules, high potent, peptides), and nutraceutical ingredients including carotenoids and vitamins.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

DongBang Future Tech & Life Co., Ltd

South Korea

DongBang Future Tech & Life Co., Ltd is a South Korean pharmaceutical company founded in 1990 that operates as a CDMO for chemical APIs and finished drugs. The company specializes in HPAPI, PROTAC, and hybrid small molecule development, with 35+ active CMC and CDMO projects for global pharma and biotech companies.

DPT Laboratories, LTD.

United States

DPT Laboratories, Ltd., a Mylan company with over 80 years of experience, is a leading CDMO specializing in semi-solid and liquid dosage forms including creams, gels, ointments, lotions, solutions, suspensions, emulsions, and aerosol formulations. The company provides integrated services from pre-formulation through commercial-scale cGMP manufacturing and packaging.

Eletis Medica

Lithuania

UAB Eletis Medica is a Lithuanian pharmaceutical company that manufactures and markets antibacterial preparations including products containing meropenem, cefazolin, ceftriaxone, and other anti-infective agents. No website is accessible and available search results show the company primarily as a pharmaceutical product marketer on CPHI, not as a contract manufacturer or CDMO.

ElevateBio (BaseCamp)

United States

ElevateBio is a US-based genetic medicines company whose BaseCamp division operates as a cGMP manufacturing CDMO for cell therapy, gene therapy, and mRNA products. BaseCamp provides development and manufacturing services from concept through commercialization, leveraging state-of-the-art facilities and proprietary technologies. The company has achieved six consecutive years of revenue growth and holds ICMC certification for its manufacturing operations.

Emmennar Pharma Private Limited

India

Emmennar Pharma Private Limited (operating as Emnar Pharma) is an Indian API manufacturer based in Hyderabad, part of the Virchow group of companies. The company specializes in the manufacture and supply of generic Active Pharmaceutical Ingredients with USFDA, EDQM (EU GMP), and KFDA-approved manufacturing facilities. Emmennar has filed 26 USMDFs, delivered 40 APIs, and holds 250+ product test licenses with 20+ products in the pipeline and 750+ employees.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Esteve CDMO (Esteve Química)

Spain

Esteve CDMO (Esteve Quimica) is a global pure-play third-party CDMO specializing in high-quality small-molecule active pharmaceutical ingredients. The company operates manufacturing sites in Spain and recently acquired Regis Technologies to expand U.S. capabilities, with FDA-registered facilities across multiple locations.

EUROAPI

France

EuroAPI is the global leader in small molecule APIs with a unique European industrial footprint of 6 manufacturing sites. Spun out from Sanofi with 15 years of oligonucleotide and 45 years of peptide experience, the company provides full CMC services from drug substance development through registration and commercial supply, including complex molecule segments like Tides (peptides and oligonucleotides).

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

Euticals (now part of Curia)

France

Euticals, now part of Curia Global, is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing across small molecules, generic APIs, sterile drug products, and biologics. Curia (which acquired Euticals through AMRI) operates an extensive global network with hundreds of FDA-registered facilities and provides end-to-end services from API manufacturing through sterile fill/finish.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

eXmoor Pharma Concepts Ltd

United Kingdom

eXmoor Pharma is a UK-based integrated cell and gene therapy CDMO with over 20 years of consultancy expertise embedded across CMC development, process development, GMP manufacturing, and commercialization. The company operates a 65,000 sq ft facility near Bristol with four Grade C process-agnostic GMP clean rooms, supporting viral vectors, autologous and allogeneic cell therapies, and RNA technologies.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fareva

Brazil

Fareva is a family-owned French CDMO and the largest in France, employing 13,000 people across 41 production sites in 13 countries with EUR 2.22 billion revenue in 2025. The company provides comprehensive pharmaceutical subcontracting from API manufacturing (including HPAPIs, cytotoxics, hormones, steroids, and controlled substances) to finished drug product manufacturing and packaging across oral, sterile injectable, nasal, ophthalmic, and semi-solid dosage forms.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

FGK Clinical Research

Czechia

FGK Clinical Research is a European full-service contract research organization (CRO) based in Munich, Germany, offering clinical development and consulting services to pharmaceutical, biotechnology, and medical device companies. It specializes in clinical trials across multiple therapeutic areas including oncology, neurology, cardiovascular, and advanced therapy medicinal products (ATMPs).

Fisher Clinical Services (Thermo Fisher)

United States

Fisher Clinical Services, part of Thermo Fisher Scientific, specializes in clinical trial supply chain management including clinical packaging, labeling, storage, and distribution of investigational medicinal products. It operates as the clinical supply arm of Thermo Fisher's broader Accelerator Drug Development platform.

Formulated Solutions

United States

Formulated Solutions is a U.S.-based CDMO providing formulation development, analytical development, manufacturing, regulatory affairs, and packaging services for pharmaceutical and consumer health products. The company offers flexible manufacturing from small-scale clinical batches to large-scale commercial production across multiple dosage forms.

Formulytica

Australia

Formulytica is an Australian specialty contract research, development and manufacturing organisation (CRDMO) with expertise in formulation, analytical method development, and drug product development. The company specializes in developing innovative drug formulations and analytical methods essential for clinical trial entry.

Fortrea

United States

Fortrea is a leading global contract research organization (CRO) spun off from Labcorp in 2023, providing Phase I through IV clinical trial management, clinical pharmacology, and market access solutions for biopharma and MedTech companies. While Fortrea has some onsite Phase I manufacturing capability for small molecule clinical supplies, its core business is clinical trial services, not contract drug manufacturing.

Fujirebio

Belgium

Fujirebio is a global in vitro diagnostics (IVD) company with over 50 years of expertise in biomarker innovation, offering CDMO services for diagnostic products. The company provides contract development and manufacturing for diagnostic partners, including reagent development, manufacturing, and clinical and regulatory services. Fujirebio is particularly known for its FDA-cleared Alzheimer's disease blood-based biomarkers on its Lumipulse platform.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.

Genovior Biotech Corporation

Taiwan

Genovior Biotech Corporation is a dedicated CDMO based in Taiwan, founded in 2015 by Dr. Steve J.P. Hsu, with more than 160 employees. The company focuses on process development, scale-up, formulation development, and productivity optimization under PIC/S GMP compliance. Genovior was acquired by Polaris Group and provides CDMO services for finished dosage form drugs.

Global Calcium Pvt. Ltd.

India

Global Calcium Pvt. Ltd. is a leading API manufacturer based in Bangalore, India, specializing in specialty APIs including benzodiazepines, ophthalmics, oncology compounds, and chelated mineral salts. The company operates 14 manufacturing plants with over 1,400 employees and exports to 80 countries. Facilities are cGMP, EU GMP, COFEPRIS certified, and WHO cGMP accredited with HACCP and ISO certifications.

GMP Laboratories of America, Inc.

United States

GMP Laboratories of America, Inc. is a US-based CDMO providing contract development and manufacturing services for oral solid dosage forms, liquids, semi-solids, and topical products. The company offers formulation development, analytical testing, stability studies, and commercial-scale manufacturing from its FDA-registered facility. It serves pharmaceutical and dietary supplement markets.

Gofarm Sp. z o.o. Sp.k

Poland

Gofarm Sp. z o.o. Sp.k is a Polish CDMO providing contract development and manufacturing services for pharmaceutical products, dietary supplements, and cosmetics. The company offers formulation development, analytical testing, stability studies, and commercial manufacturing for oral solid dosage forms, liquids, and semi-solid products. It operates from EU GMP-compliant facilities in Poland.

GreenLight Clinical

Australia

GreenLight Clinical is an Australian full-service Contract Research Organisation (CRO) specializing in ophthalmology, oncology, rare diseases, and gene and cell therapy clinical trials. The company provides clinical monitoring, project management, data management, regulatory affairs, and site management services for biotech and pharmaceutical sponsors.

Groupe PARIMA

Canada

Groupe PARIMA is a Canadian CDMO founded in 1994 specializing in the development and manufacturing of non-sterile liquids, suspensions, and semi-solid drug products. Operating from a 67,000 sq ft facility in Montreal, the company provides turnkey services from formulation development through commercial production, supplying drug products to over 30 global markets.

Groupe SYNERLAB CDMO

France

Groupe SYNERLAB (now operating as Meribel Pharma Solutions) is a mid-size European CDMO with an integrated network of manufacturing sites across Europe, providing end-to-end services from API manufacturing through finished dosage forms. The company specializes in sterile multidoses, sterile and non-sterile lyophilized products, sachets, stick packs, oral solid dose, liquids, and semi-solids.

Grünenthal PRO (Grünenthal CDMO)

Chile

Duplicate entry of Grunenthal PRO (company ID 8756785b). Grunenthal PRO is the contract manufacturing arm of Grunenthal Group, operating five specialized plants with vertically integrated manufacturing from active substance to finished products. Approximately 50% of total production is for third-party clients across 100+ countries.

Grupo Azevedos (Sofarimex)

Portugal

Grupo Azevedos, operating through its Sofarimex manufacturing unit, is a Portuguese CDMO specializing in freeze-dried injectables and sterile eye drops, with over 20 years of contract manufacturing experience. The company manufactures pharmaceutical medicines and health products for third parties across non-sterile solid, semi-solid, and liquid forms, as well as sterile products, and holds manufacturing licenses from INFARMED and multiple international authorities.

Gruppo Farma Impresa S.r.l.

Italy

Gruppo Farma Impresa is an Italian contract manufacturer specializing in medical devices based on substances, food supplements, and dermocosmetics, offering private label production (conto terzi) and out-licensing of over 1,000 ready-to-market products. The company provides formulation development, R&D with over 200 new formulations annually, regulatory affairs support, and clinical trial services across multiple therapeutic areas.

GTP Bioways

France

Duplicate entry of GTP Bioways (company ID 1f8658ec). GTP Bioways, acquired by Olon Group in 2024, is a French biologics CDMO specializing in process development and GMP manufacturing of monoclonal antibodies, recombinant proteins, bispecifics, ADCs, and nanodrugs across four sites in France.

Guangzhou Packgene Biotechnology Co Ltd (PackGene)

China

PackGene Biotech is a Chinese cell and gene therapy CRO and CDMO providing comprehensive AAV, lentivirus, mRNA, and plasmid services from discovery through GMP manufacturing. The company operates a 120,000 sq ft GMP facility for viral vector production and has served over 1,000 clients globally with more than 50,000 projects delivered.

Guangzhou RiboBio Co., Ltd.

China

Guangzhou RiboBio Co., Ltd. operates a CDMO/CMO platform (RiboPharm) that is Asia's largest GMP oligonucleotide API manufacturer, with over 20,000 sqm of planned production area. The company provides comprehensive oligonucleotide drug discovery, process and analytical development, CMC services, API production, and aseptic fill-finish, serving global pharmaceutical companies in bringing nucleic acid drugs from development to market.

Hapila GmbH

Germany

Hapila GmbH is an independent chemical-pharmaceutical CDMO based in Gera, Thuringia, Germany, specializing in the development and GMP manufacturing of active pharmaceutical ingredients, including high-potency APIs. The company provides services from early development through to market supply for approved medicinal products.